Loading company details...
Beta
Latest Form 4 (Aug 12, 2026): Carl L. Gordon (Director): Conversion of 1,039,996 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Carl L. Gordon | Conversion | 1,039,996 | n/a |
| Aug 12, 2026 | ORBIMED ADVISORS LLC | Conversion | 1,039,996 | n/a |
| Aug 10, 2026 | John P. Schmid | Purchase | 6,000 | $96.0K |
| Aug 10, 2026 | Carl L. Gordon | Grant/Award | 23,904 | n/a |
| Aug 10, 2026 | Bihua Chen | Conversion | 1,599,993 | n/a |
| Aug 10, 2026 | Sundeep Agrawal | Conversion | 578,524 | n/a |
| Aug 10, 2026 | Jason A. Keyes, Chief Financial Officer | Purchase | 700 | $11.2K |
| Aug 10, 2026 | Vincent Paul Liptak, General Counsel | Purchase | 2,500 | $39.5K |
| Aug 10, 2026 | Geoffrey Raymond Oxnard, Chief Medical Officer | Grant/Award | 61,783 | n/a |
| Aug 10, 2026 | Yishan Li, Executive Chairman | Conversion | 1,600,682 | n/a |